Modern Biopharmaceuticals: Design, Development and Optimization

分類: 图书,进口原版,Medicine(医学),Pharmacology(药理学),Pharmacy,
品牌: J?rg Kn?blein
基本信息出版社:Wiley-VCH; 1 (2005年12月5日)精装:2022页正文语种:英语ISBN:352731184X条形码:9783527311842商品尺寸:12.2 x 17 x 24 cm商品重量:3.9 KgASIN:352731184X商品描述内容简介Due to the impressive accumulation of out-standing results, presented by brilliant, privileged and creative thinkers, this unique book reads like the ‘Who is Who’ of biotechnology. Never before has such an impressive group of individuals contributed to one biotechnology book, including Nobel Prize laureates Robert Huber, Thomas R. Cech, and Manfred Eigen as well as authors from the world's most famous academic institutes and biotech companies, such as ETH Zurich, MIT, Stanford, Yale, Princeton, Harvard Medical School, Max-Planck-Institute, Fraunhofer-Institute, Moscow Academy of Sciences, London Imperial College and Baxter, Invitrogen, MorphoSys, Roche, and Schering AG.Published as a comprehensive four volume set, this title also includes a CD-ROMcontaining additional information and videos.Modern Biopharmaceuticals describes:THE FIRST cloned human embryoTHE FIRST myocardial regeneration with embryonic stem cellsTHE FIRST artificial kidneyTHE FIRST biopharmaceutical from a transgenic animalTHE FIRST individualized medicineTHE FIRST plasma-free Factor VIIITHE FIRST approved human cell lineTHE FIRST oral insulin, etc.“... an outstanding collection of articles from groundbreaking scientists, comprehensively describing the many novel ways cells are being deployed toward human good ...” James D. Watson, “DNA Codebreaker” & Nobel Prize Laureate (Physiology or Medicine, 1962)Modern Biopharmaceuticals is an essential reference work for biotechnologists, clinicians, medical doctors, pharmacists, pharmaceutical chemists, bio-chemists, molecular biologists, medicinal chemists, as well as all those working in the biotechnological and pharmaceutical industries, or medicinal institutes.作者简介Dr. Jörg Knäblein studied Biotechnolgy / Chemical Engineering. at the Society for Biotechnology Research (GBF) in Braunschweig, Germany and Biochemistry at the Max-Planck-Institute for Biochemistry. He received his Ph.D. from the Max-Planck-Institute for Biochemistry in Martinsried / Munich where he worked in the group of Professor Huber (Nobelprize laureate in 1988).
AWARDS:
Riedel-de Haen-Stiftung
Government / Ministery of science
Nomination for the Max-Buchner-Award from DECHEMA (Society for Biotechnolgy and Chemical Engineering)
Winner of the McKinsey business plan contest